Qulipta (atogepant)

pCPA File Number: 22394

Negotiation Status:

Active Negotiation

Indication(s):

For the prevention of episodic migraine in adults

Sponsor/Manufacturer:

AbbVie Corporation

CADTH Project Number:

SR0724

pCPA Engagement Letter Issued:

2023-08-16

Negotiation Process Concluded:

Not Applicable